Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Puneet Puri

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
Journal of Hepatology|September 24, 2022
A double-blind randomized placebo-controlled trial of albumin in outpatients with hepatic encephalopathy: HEAL studyAndrew Fagan, Edith A Gavis, Mary Leslie Gallagher, et al.
Hepatology (Baltimore, Md.)|May 13, 2022
Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLDEkaterina Smirnova, Mark D Muthiah, Nicole Narayan, et al.
Digestive Diseases and Sciences|April 24, 2020
Liver Transplant Is Associated with Sustained Improvement in Tandem Gait and Risk of FallsChathur Acharya, Melanie B White, Andrew Fagan, et al.
The American Journal of Gastroenterology|June 7, 2018
Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in CirrhosisJasmohan S Bajaj, Chathur Acharya, Andrew Fagan, et al.
Metabolic Brain Disease|March 5, 2014
Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with Rifaximin in Cirrhosis: implications for the gut-liver-brain axisVishwadeep Ahluwalia, James B Wade, Douglas M Heuman, et al.
Metabolic Brain Disease|June 27, 2016
Cirrhotic patients have good insight into their daily functional impairment despite prior hepatic encephalopathy: comparison with PROMIS normsJasmohan S Bajaj, Melanie B White, Ariel B Unser, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 29, 2018
Association of Pretransplant Renal Function With Liver Graft and Patient Survival After Liver Transplantation in Patients With Nonalcoholic SteatohepatitisMiklos Z Molnar, Kiran Joglekar, Yu Jiang, et al.
Journal of Hepatology|January 12, 2025
Microbiota transplant for hepatic encephalopathy in cirrhosis: The THEMATIC trialJasmohan S Bajaj, Andrew Fagan, Edith A Gavis, et al.
The American Journal of Gastroenterology|June 18, 2021
Liver-Unrelated Comorbid Conditions Do Not Affect Cognitive Performance or Hepatic Encephalopathy Progression in CirrhosisChathur Acharya, Omar Nadhem, Jawaid Shaw, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 28, 2014
Effects of obstructive sleep apnea on sleep quality, cognition, and driving performance in patients with cirrhosisJasmohan S Bajaj, Leroy R Thacker, David Leszczyszyn, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Journal of Hepatology|September 24, 2022
A double-blind randomized placebo-controlled trial of albumin in outpatients with hepatic encephalopathy: HEAL studyAndrew Fagan, Edith A Gavis, Mary Leslie Gallagher, et al.
Hepatology (Baltimore, Md.)|May 13, 2022
Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLDEkaterina Smirnova, Mark D Muthiah, Nicole Narayan, et al.
Digestive Diseases and Sciences|April 24, 2020
Liver Transplant Is Associated with Sustained Improvement in Tandem Gait and Risk of FallsChathur Acharya, Melanie B White, Andrew Fagan, et al.
The American Journal of Gastroenterology|June 7, 2018
Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in CirrhosisJasmohan S Bajaj, Chathur Acharya, Andrew Fagan, et al.
Metabolic Brain Disease|March 5, 2014
Enhancement of functional connectivity, working memory and inhibitory control on multi-modal brain MR imaging with Rifaximin in Cirrhosis: implications for the gut-liver-brain axisVishwadeep Ahluwalia, James B Wade, Douglas M Heuman, et al.
Metabolic Brain Disease|June 27, 2016
Cirrhotic patients have good insight into their daily functional impairment despite prior hepatic encephalopathy: comparison with PROMIS normsJasmohan S Bajaj, Melanie B White, Ariel B Unser, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 29, 2018
Association of Pretransplant Renal Function With Liver Graft and Patient Survival After Liver Transplantation in Patients With Nonalcoholic SteatohepatitisMiklos Z Molnar, Kiran Joglekar, Yu Jiang, et al.
Journal of Hepatology|January 12, 2025
Microbiota transplant for hepatic encephalopathy in cirrhosis: The THEMATIC trialJasmohan S Bajaj, Andrew Fagan, Edith A Gavis, et al.
The American Journal of Gastroenterology|June 18, 2021
Liver-Unrelated Comorbid Conditions Do Not Affect Cognitive Performance or Hepatic Encephalopathy Progression in CirrhosisChathur Acharya, Omar Nadhem, Jawaid Shaw, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 28, 2014
Effects of obstructive sleep apnea on sleep quality, cognition, and driving performance in patients with cirrhosisJasmohan S Bajaj, Leroy R Thacker, David Leszczyszyn, et al.
Pageof 12